BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 19, 2002
View Archived Issues
Trimeris, Roche Fusion Inhibitor Succeeds In Phase III HIV Trial
A fusion inhibitor for HIV patients being developed by Trimeris Inc. and Hoffmann-La Roche Inc. produced better than expected results in a Phase III trial. (BioWorld Today)
Read More
Lynx Raises $22.6M, Cuts Staff By 30 Percent To Focus Efforts
Read More
Mammals, Research Nematodes Share Proteins Crucial For Stress Response, Mammalian Life Spans
Read More
Senesco Using Funding To Move Plant Technology Into Humans
Read More
Other News To Note
Read More